Abstract: Systems and devices for an updatable blood pump are disclosed herein. The blood pump can be part of a mechanical circulatory support system that can include a system controller and the blood pump. The blood pump can include a rotary motor and a control unit that can communicate with the system controller. The system controller can initiate the update process and can provide the update to the blood pump. Upon initiation of the update process, the control unit can stop the rotary motor. While the rotary motor is stopped, the blood pump can be updated. At the completion of the update, the rotary pump can be restarted.

Abstract: An implantable blood pump includes a control unit storing patient specific settings. The control unit is configured to store patient specific settings. The patient specific settings can be used to determine a target operating speed for the blood pump and/or a target operating mode for the blood pump. The patient specific settings can include at least one of an operating mode for the pump, a set speed for the pump, a lower speed limit for the pump, a patient hematocrit value, a patient hematocrit date, a patient blood density, and a periodic log rate for event and periodic data.

Abstract: Systems and devices for an adaptable blood pump are disclosed herein. The blood pump can be part of a mechanical circulatory support system that can include a system controller and the blood pump. The blood pump can include a rotary motor and a control unit that can communicate with the system controller. The blood pump can determine when communication with the system controller is established or has been lost. The blood pump can retrieve one or several back-up parameters when communication with the system controller has been lost, and can operate according to these back-up parameters.

Abstract: Systems and devices for an updatable blood pump are disclosed herein. The blood pump can be part of a mechanical circulatory support system that can include a system controller and the blood pump. The blood pump can include a rotary motor and a control unit that can communicate with the system controller. The system controller can initiate the update process and can provide the update to the blood pump. Upon initiation of the update process, the control unit can stop the rotary motor. While the rotary motor is stopped, the blood pump can be updated. At the completion of the update, the rotary pump can be restarted.

Abstract: Methods, systems, and devices for an adaptable blood pump are disclosed herein. The blood pump can be part of a mechanical circulatory support system that can include a system controller and the blood pump. The blood pump can include a rotary motor and a control unit that can communicate with the system controller. The blood pump can determine when communication with the system controller is established or has been lost. The blood pump can retrieve one or several back-up parameters when communication with the system controller has been lost, and can operate according to these back-up parameters.

Abstract: Systems and devices for an updatable blood pump are disclosed herein. The blood pump can be part of a mechanical circulatory support system that can include a system controller and the blood pump. The blood pump can include a rotary motor and a control unit that can communicate with the system controller. The system controller can initiate the update process and can provide the update to the blood pump. Upon initiation of the update process, the control unit can stop the rotary motor. While the rotary motor is stopped, the blood pump can be updated. At the completion of the update, the rotary pump can be restarted.

Abstract: The present invention relates to an alkyl glycoside sulfomethylsuccinate having the formula R1—O—Sn—R2 wherein R1 is an alkyl radical having 6 to 30 carbon atoms, S is a monosaccharide moiety, and R2 is a sulfomethylsuccinate moiety. Furthermore the present invention relates to a process for making this alkyl glycoside sulfomethylsuccinate and to an alkyl glycoside itaconate which is a useful intermediate for use in this process. Furthermore the present invention relates to a cosmetic composition comprising the alkyl glycoside sulfomethylsuccinate and to the use of the alkyl glycoside sulfomethylsuccinate for improving the foam stability of a cosmetic composition.

Abstract: Thermoplastic moulding composition (F), comprising: A) from 5 to 80% by weight of a graft polymer (A) having bimodal particle size distribution and a moisture content of 0 to 27% by weight, made, based on (A), a1) from 40 to 90% by weight of an elastomeric particulate graft base (a1), obtained by emulsion polymerization of, based on (a1), a11) from 70 to 100% by weight of at least one conjugated diene, or of at least one C1-8-alkyl acrylate, or of mixtures of these, a12) from 0 to 30% by weight of at least one other monoethylenically unsaturated monomer and a13) from 0 to 10% by weight of at least one polyfunctional, cross linking monomer; a2) from 10 to 60% by weight of a graft a2), made, based on a2), a21) from 64 to 76% by weight of at least one vinyl aromatic monomer, a22) from 24 to 36% by weight of acrylonitrile, a23) from 0 to 30% by weight of at least one other monoethylenically unsaturated monomer, and a24) from 0 to 10% by weight of at least one polyfunctional, cross linking monomer; B) from 10 to 9

Abstract: Methods, systems, and devices for an updatable blood pump are disclosed herein. The blood pump can be part of a mechanical circulatory support system that can include a system controller and the blood pump. The blood pump can include a rotary motor and a control unit that can communicate with the system controller. The system controller can initiate the update process and can provide the update to the blood pump. Upon initiation of the update process, the control unit can stop the rotary motor. While the rotary motor is stopped, the blood pump can be updated. At the completion of the update, the rotary pump can be restarted.

Abstract: A chemical mechanical polishing (CMP) composition comprising: (A) inorganic particles, organic particles, or a mixture or composite thereof, (B) at least one type of an organic polymeric compound as a dispersing agent or charge reversal agent comprising a phosphonate (P(?O)(OR1)(OR2) or phosphonic acid (P(?O)(OH)2) moiety or their deprotonated forms as pendant groups, wherein R1 is alkyl, aryl, alkylaryl, or arylalkyl, R2 is H, alkyl, aryl, alkylaryl, or arylalkyl, and (C) an aqueous medium.

Abstract: The present invention relates to a continuous process for the manufacture of highly-branched homo- or copolymers of C3-C8 ethylenically unsaturated mono- or dicarboxylic acid as well as the anhydrides and salts thereof (monomer A) by means of free-radical polymerization of monomer A and optionally water-soluble, monethylenically unsaturated comonomers (monomer B) in an aqueous medium in the presence of at least one water-soluble initiator, wherein the polymerization takes place in at least one tubular reactor segment.

Abstract: Process for preparing polymers comprising S-vinylthioalkanol as monomer by radical polymerization, the polymerization being carried out in aqueous solution, with the proviso that no N-vinylpyrrolidone as monomer is used for preparing the polymers, and also polymers prepared by such processes. Copolymer consisting of S-vinyl-2-thioethan-1-ol and one or more ethylenically unsaturated monomers selected from the group consisting of acrylic acid, itaconic acid, maleic acid, maleic anhydride, and vinylphosphonic acid. Mixtures, preferably aqueous compositions, comprising polymers or copolymers. Use of polymers, copolymers, or aqueous compositions as concrete plasticizers, wetting agents, in cosmetics, as adhesive constituent, in emulsion polymerization, for metal surface treatment, in coatings applications, in paints, in laundry detergents, in washing detergents, as encapsulating material or as enveloping material.

Abstract: Unsaturated compounds of the general formula (I) where R1, R2, R3 are the same or different and are each independently H, CH3, R4 is a linear or branched C1-C30-alkylene, R5, R6 are the same or different and are each independently, H, C1-C20-alkyl, C3-C15-cycloalkyl, aryl, —CH2—O—C1-C20-alkyl, —CH2—O—C2-C20-alkenyl, where R5 and R6 may together form a C3-C6-alkylene, R7, is the same or different and is independently, H, C1-C4-alkyl, R8 is C1-C22-alkyl, C2-C22-alkenyl, and n is an integer from 2 to 200. Mixtures and polymers comprising compounds of the general formula (I). A method for preparing polymers wherein a free-radical polymerization of monomers comprising unsaturated compounds of the general formula (I) is carried out. A process for preparing polymers comprising polymer-analogous reactions.

Abstract: The present invention relates to a continuous process for the manufacture of highly-branched homo- or copolymers of C3-C8 ethylenically unsaturated mono- or dicarboxylic acid as well as the anhydrides and salts thereof (monomer A) by means of free-radical polymerization of monomer A and optionally water-soluble, monethylenically unsaturated comonomers (monomer B) in an aqueous medium in the presence of at least one water-soluble initiator, wherein the polymerization takes place in at least one tubular reactor segment.

Abstract: Described is an di(alkyl-glycoside) sulfomethylsuccinate having the formula R1—O—Sn—R2—Sn—O—R1 wherein R1 is an alkyl radical having 6 to 30 carbon atoms, S is a monosaccharide moiety, and R2 is a sulfomethylsuccinate moiety. Furthermore, described is a process for making this di(alkyl-glycoside) sulfomethylsuccinate and to an di(alkyl-glycoside) itaconate which is a useful intermediate for use in this process. Also described is a cosmetic composition comprising the alkyl glycoside sulfomethylsuccinate.

Abstract: Methods, systems, and devices for an adaptable blood pump are disclosed herein. The blood pump can be part of a mechanical circulatory support system that can include a system controller and the blood pump. The blood pump can include a rotary motor and a control unit that can communicate with the system controller. The blood pump can determine when communication with the system controller is established or has been lost. The blood pump can retrieve one or several back-up parameters when communication with the system controller has been lost, and can operate according to these back-up parameters.

Abstract: An implantable blood pump includes a control unit storing patient specific settings. The control unit is configured to store patient specific settings. The patient specific settings can be used to determine a target operating speed for the blood pump and/or a target operating mode for the blood pump. The patient specific settings can include at least one of an operating mode for the pump, a set speed for the pump, a lower speed limit for the pump, a patient hematocrit value, a patient hematocrit date, a patient blood density, and a periodic log rate for event and periodic data.

Abstract: Methods, systems, and devices for an updatable blood pump are disclosed herein. The blood pump can be part of a mechanical circulatory support system that can include a system controller and the blood pump. The blood pump can include a rotary motor and a control unit that can communicate with the system controller. The system controller can initiate the update process and can provide the update to the blood pump. Upon initiation of the update process, the control unit can stop the rotary motor. While the rotary motor is stopped, the blood pump can be updated. At the completion of the update, the rotary pump can be restarted.

Abstract: A chemical mechanical polishing (CMP) composition comprising: (A) inorganic particles, organic particles, or a mixture or composite thereof, (B) at least one type of an organic polymeric compound as a dispersing agent or charge reversal agent comprising a phosphonate (P(?O)(OR1)(0R2) or phosphonic acid (P(?O)(OH)2) moiety or their deprotonated forms as pendant groups, wherein R1 is alkyl, aryl, alkylaryl, or arylalkyl, R2 is H, alkyl, aryl, alkylaryl, or arylalkyl, and (C) an aqueous medium.

Abstract: Thermoplastic moulding composition (F), comprising: A) from 5 to 80% by weight of a graft polymer (A) having bimodal particle size distribution and a moisture content of 0 to 27% by weight, made, based on (A), a1) from 40 to 90% by weight of an elastomeric particulate graft base (a1), obtained by emulsion polymerization of based on (a1), a11) from 70 to 100% by weight of at least one conjugated diene, or of at least one C1-8-alkyl acrylate, or of mixtures of these, a12) from 0 to 30% by weight of at least one other monoethylenically unsaturated monomer and a13) from 0 to 10% by weight of at least one polyfunctional, cross linking monomer; a2) from 10 to 60% by weight of a graft a2), made, based on a2), a21) from 64 to 76% by weight of at least one vinyl aromatic monomer, a22) from 24 to 36% by weight of acrylonitrile, a23) from 0 to 30% by weight of at least one other monoethylenically unsaturated monomer, and a24) from 0 to 10% by weight of at least one polyfunctional, cross linking monomer; B) from 10 to 94